We help diagnostics companies and researchers turn lateral flow assays into commercially ready products — from the chemistry and strip design all the way through to a working device ready for market.
There is no shortage of good ideas in the LFA space. What holds teams back is the transition — from a working prototype to a product that can be manufactured consistently, validated clinically, and certified to the standards a regulator actually requires.
Having worked within small and medium-sized diagnostics businesses, we know what it takes to make R&D work alongside — not against — a Quality department. That interdepartmental reality is something most technical consultants have not lived inside.
We bring industrial insight to science, and scientific rigor to industry. Without both, products fail.
Our work spans the full development arc — from initial feasibility and method development through to performance validation and submission-ready documentation. We are not a referral service; when we take on a project, we do the work.
Who we work with
Every service is delivered from a single point of accountability — the same expertise that designed your conjugate also runs your clinical trial and writes your SOPs.
One of the most costly mistakes in LFA development is applying the wrong quality framework from the start. Getting this right shapes everything — your facility, your documentation, your clinical program, and your timeline.
Engagements are scoped to the problem — from focused technical sprints to longer advisory retainers. Remote and on-site arrangements are both available; location is not a constraint.
Most development failures aren't random. They follow predictable patterns. Here's what we see most often, and how to get unstuck.
Most assay problems are diagnosable.
The key is systematic elimination — starting with the most likely root cause and working outward. If your strip isn't performing and you're not sure why, a one-hour diagnostic conversation usually identifies the problem.
Whether you're an academic with a promising LFA technology wondering what it takes to get to market, or an entrepreneur finding that the regulatory environment is more complex than expected — we'd like to hear from you.